News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Calistoga Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference


1/5/2011 9:10:25 AM

(BUSINESS WIRE)--Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that Carol Gallagher, President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011 at 2:30 p.m. Pacific Time. The conference is taking place at the Westin St. Francis Hotel in San Francisco, California.

Read at Business Wire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES